Vitruvia Medical AG (MUN: 991)

Vitruvia Medical AG Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1.75	1.75	1.42	1.95	5.6
Other Revenue	0.01	0.01	0.11	0.02	0.17
Revenue	1.76	1.76	1.53	1.97	5.77
Revenue Growth (YoY)	15.22%	15.22%	-22.42%	-65.94%	-
Cost of Revenue	0.46	0.46	0.4	0.85	3.74
Gross Profit	1.3	1.3	1.12	1.11	2.03
Selling, General & Admin	1.24	1.24	2.03	1.81	2.99
Operating Expenses	1.67	1.67	2.47	2.24	3.34
Operating Income	-0.37	-0.37	-1.34	-1.13	-1.31
Other Non Operating Income (Expenses)	-0.13	-0.13	-0.03	-0.05	-0.18
EBT Excluding Unusual Items	-0.5	-0.5	-1.37	-1.18	-1.5
Other Unusual Items	-	-	-0.09	-6.95	-
Pretax Income	-0.5	-0.5	-1.47	-8.13	-1.5
Income Tax Expense	0.03	0.03	0.02	-0	0.05
Net Income	-0.54	-0.54	-1.48	-8.13	-1.54
Net Income to Common	-0.54	-0.54	-1.48	-8.13	-1.54
Shares Outstanding (Basic)	2	2	2	-	1
Shares Outstanding (Diluted)	2	2	2	-	1
Shares Change (YoY)	36.55%	36.55%	-	-	-
EPS (Basic)	-0.23	-0.23	-0.88	-	-1.05
EPS (Diluted)	-0.23	-0.23	-0.88	-	-1.05
Free Cash Flow	-	-	-	-	-3.12
Free Cash Flow Per Share	-	-	-	-	-2.12
Gross Margin	73.92%	73.92%	73.57%	56.52%	35.13%
Operating Margin	-21.08%	-21.08%	-88.12%	-57.36%	-22.74%
Profit Margin	-30.46%	-30.46%	-97.31%	-413.55%	-26.76%
Free Cash Flow Margin	-	-	-	-	-54.11%
EBITDA	0.06	0.06	-0.91	-0.78	-0.96
EBITDA Margin	3.47%	3.47%	-59.79%	-39.45%	-16.64%
D&A For EBITDA	0.43	0.43	0.43	0.35	0.35
EBIT	-0.37	-0.37	-1.34	-1.13	-1.31
EBIT Margin	-21.08%	-21.08%	-88.12%	-57.36%	-22.74%
Revenue as Reported	1.76	1.76	1.53	1.97	5.77
Advertising Expenses	0.06	0.06	0.05	0.03	0.04

Source: S&P Capital IQ. Standard template. Financial Sources.